Rhetoric and Hype: Where’s the ‘Ethics’ in Pharmacogenomics?

Author： Williams-Jones B.   Corrigan O.P.  

Publisher： Adis International

ISSN： 1175-2203

Source： American Journal of PharmacoGenomics, Vol.3, Iss.6, 2003-01, pp. : 375-383

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenomics: hype, hope, or metamorphosis of molecular medicine and pharmaceuticals

By Amin A.R.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 12, 2002-12 ,pp. : 583-583

Elsevier

Access to resources Recommend Favorite

Pharmacogenomics: where does Britain stand?

By Hudson John  

Pharmacogenomics, Vol. 13, Iss. 1, 2012-01 ,pp. : 1-3

Future Medicine

Access to resources Recommend Favorite

Forensic Toxicology and Pharmacogenomics: Hype or Hope For Higher Standards in Forensic Medicine?

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 8, Iss. 2, 2010-06 ,pp. : 139-145

Bentham Science Publishers

Access to resources Recommend Favorite

Breast cancer pharmacogenomics: where we are going

By Newman William G   Flockhart Dave  

Pharmacogenomics, Vol. 13, Iss. 6, 2012-04 ,pp. : 629-631

Future Medicine

Access to resources Recommend Favorite

Clinical Pharmacogenomics of Thiopurine S-methyltransferase

By  

Current Clinical Pharmacology, Vol. 1, Iss. 1, 2006-01 ,pp. : 119-128

Bentham Science Publishers

Access to resources Recommend Favorite